Putting methotrexate prescribing research into practice

[et_pb_section fb_built=”1″ _builder_version=”4.4.8″][et_pb_row _builder_version=”4.4.8″][et_pb_column type=”4_4″ _builder_version=”4.4.8″][et_pb_text _builder_version=”4.4.8″ hover_enabled=”0″]

New research published in the BJGP from Dr Ben Goldacre’s team in Oxford found that 23% of GPs still prescribed different strength methotrexate tablets (10mg and 2.5mg) to the same person in the past year — against the safety advice.

Overall though, it is improving and in the past 10 years, prescriptions of 10mg tablets have dropped from 9% to 3%. Brian MacKenna, Pharmacist Researcher, recommends every GP should visit and review their own prescribing — the clear message for practice from the research is that GPs should check their prescribing and start processes to switch people from 10mg methotrexate tablets.

Watch the short videos below and read the paper:


[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.4.8″][et_pb_column type=”1_2″ _builder_version=”4.4.8″][et_pb_number_counter title=”Deaths from methotrexate poisoning in England and Wales (1993-2017)” number=”21″ percent_sign=”off” _builder_version=”4.4.8″ title_level=”h2″ title_font_size=”18px” number_text_color=”#000000″ motion_trigger_start=”bottom”][/et_pb_number_counter][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.4.8″][et_pb_number_counter title=”Number of practices who prescribed 10mg methotrexate in England in 2017 (Total number of practices = 7349)” number=”1689″ percent_sign=”off” _builder_version=”4.4.8″ title_level=”h2″ title_font_size=”18px” number_text_color=”#000000″ motion_trigger_start=”bottom”][/et_pb_number_counter][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.4.8″][et_pb_column type=”4_4″ _builder_version=”4.4.8″][et_pb_text _builder_version=”4.4.8″ hover_enabled=”0″]

The research found that prescribing of 10mg methotrexate tablets has fallen, as a proportion of methotrexate prescribing, from 9.1% in 2010 to 3.4% in 2018.

Safe methotrexate prescribing is a priority NHS concern and is listed as a Never Event.

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row admin_label=”Row” _builder_version=”4.4.8″][et_pb_column type=”4_4″ _builder_version=”4.4.8″][et_pb_divider _builder_version=”4.4.8″][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.4.8″][et_pb_column type=”1_3″ _builder_version=”4.4.8″][et_pb_text _builder_version=”4.4.8″]

The Research

Brian MacKenna, Pharmacist Researcher at University of Oxford, talks about their new research into methotrexate prescribing. Read the paper:

[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.4.8″][et_pb_text _builder_version=”4.4.8″]

In Practice

Dr Kevin Barrett, a GP, tells us about how his practice, many years ago, had a significant event involving a patient who had 10mg methotrexate tablets. Despite thinking they had banned 10mg tablets the highlighted a new patient who had slipped through the net.

[/et_pb_text][/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.4.8″][et_pb_text _builder_version=”4.4.8″]


Ben Goldacre gives a short walk-through on how works and how everyone, and every practice, can access prescribing data.

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.4.8″][et_pb_row _builder_version=”4.4.8″][et_pb_column type=”4_4″ _builder_version=”4.4.8″][et_pb_text _builder_version=”4.4.8″]

Article: Trends and variation in unsafe prescribing of methotrexate

Download the PDF at


The BJGP is the world-leading primary care journal. At BJGP Life we add multi-media comment and opinion for the primary care community.

Notify of

This site uses Akismet to reduce spam. Learn how your comment data is processed.

1 Comment
Newest Most Voted
Inline Feedbacks
View all comments

[…] You can read the full paper and access more videos on BJGP Life about putting our methotrexate research into practice. […]

Previous Story

General practice post COVID: time to put equity at the heart?

Next Story

Health inequality and COVID: Two centuries of social murder

Latest from Research

Yonder: Farewell

"I remain fascinated by, and grateful for, the excellent research that sheds light on all aspects

Would love your thoughts, please comment.x
Skip to toolbar